Artificial Intelligence-Enhanced Models to Predict Light Chain Amyloidosis from Patients with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7230-7232
10.1182/blood-2022-168119